MX2008013017A - Tratamiento de malignidades hematologicas con fts y un inhibidor de tirosina cinasa de bcr-abl. - Google Patents
Tratamiento de malignidades hematologicas con fts y un inhibidor de tirosina cinasa de bcr-abl.Info
- Publication number
- MX2008013017A MX2008013017A MX2008013017A MX2008013017A MX2008013017A MX 2008013017 A MX2008013017 A MX 2008013017A MX 2008013017 A MX2008013017 A MX 2008013017A MX 2008013017 A MX2008013017 A MX 2008013017A MX 2008013017 A MX2008013017 A MX 2008013017A
- Authority
- MX
- Mexico
- Prior art keywords
- fts
- bcr
- tyrosine kinase
- kinase inhibitor
- abl tyrosine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
Están descritos métodos para tratar una malignidad hematológica mediante administrar a un humano que necesita de las mismas cantidades efectivas de FTS (Ácido Farnesiltiosalicilico), o varios análogos del mismo, o una sal farmacéuticamente aceptable del mismo, opcionalmente en combinación con un inhibidor de tirosina cinasa de Bcr-Abl. También están descritas composiciones farmacéuticas que comprende FTS, o varios análogos del mismo, o una sal farmacéuticamente aceptable del mismo, un inhibidor de tirosina cinasa de Bcr-Abl, preferiblemente Imatinib y un portador farmacéuticamente aceptable.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79105006P | 2006-04-11 | 2006-04-11 | |
| PCT/IL2007/000439 WO2007116396A1 (en) | 2006-04-11 | 2007-04-10 | Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008013017A true MX2008013017A (es) | 2008-11-27 |
Family
ID=38218987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008013017A MX2008013017A (es) | 2006-04-11 | 2007-04-10 | Tratamiento de malignidades hematologicas con fts y un inhibidor de tirosina cinasa de bcr-abl. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090298843A1 (es) |
| EP (1) | EP2004170A1 (es) |
| CA (1) | CA2648518C (es) |
| MX (1) | MX2008013017A (es) |
| WO (1) | WO2007116396A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006017728D1 (de) | 2005-11-28 | 2010-12-02 | Univ Ramot | Krebsbehandlung mittels fts und 2-deoxyglucose |
| WO2011051938A1 (en) * | 2009-10-26 | 2011-05-05 | Ramot At Tel-Aviv University Ltd. | Composition for treatment of thyroid cancer with fts and analogs thereof |
| JP2013508458A (ja) * | 2009-10-26 | 2013-03-07 | ラモット・アット・テル−アヴィヴ・ユニヴァーシティ・リミテッド | Ｆｔｓとｈｄａｃ阻害剤との組合せを用いたがん治療 |
| US9738614B2 (en) | 2011-10-07 | 2017-08-22 | Pisces Therapeutics, Llc | Malignant and non-malignant disease treatment with Ras antagonists |
| ES2642843T3 (es) | 2011-10-07 | 2017-11-20 | Pisces Therapeutics Llc | Tratamiento de enfermedad maligna y no maligna con antagonistas de Ras |
| GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| RU2018120330A (ru) | 2015-11-02 | 2019-12-04 | Йейл Юниверсити | Химерные соединения, осуществляющие нацеливание для протеолиза, и способы их получения и применения |
| CA3095494C (en) | 2018-04-04 | 2023-11-07 | Arvinas Operations, Inc. | Modulators of proteolysis and associated methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202456A (en) * | 1991-04-15 | 1993-04-13 | The President And Fellows Of Harvard College | Compounds for inhibition of protein methylation |
| IL107587A (en) * | 1993-11-12 | 1998-08-16 | Univ Ramot | Farnesyl geranyl or geranyl-geranyl derivatives pharmaceutical compositions containing them and methods for their preparation |
| US6462086B1 (en) * | 1999-06-18 | 2002-10-08 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Non-malignant disease treatment with Ras antagonists |
| WO2004004644A2 (en) * | 2002-07-05 | 2004-01-15 | Beth Israel Deaconess Medical Center | Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms |
-
2007
- 2007-04-10 US US12/225,944 patent/US20090298843A1/en not_active Abandoned
- 2007-04-10 WO PCT/IL2007/000439 patent/WO2007116396A1/en active Application Filing
- 2007-04-10 EP EP07736179A patent/EP2004170A1/en not_active Withdrawn
- 2007-04-10 MX MX2008013017A patent/MX2008013017A/es unknown
- 2007-04-10 CA CA2648518A patent/CA2648518C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20090298843A1 (en) | 2009-12-03 |
| CA2648518C (en) | 2012-06-26 |
| CA2648518A1 (en) | 2007-10-18 |
| EP2004170A1 (en) | 2008-12-24 |
| WO2007116396A1 (en) | 2007-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2008013017A (es) | Tratamiento de malignidades hematologicas con fts y un inhibidor de tirosina cinasa de bcr-abl. | |
| MX2009008253A (es) | Derivados de 2-aminopiridina utiles como inhibidores de cinasa. | |
| MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
| SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| MX2009006345A (es) | Compuestos utiles como inhibidores de proteina cinasa. | |
| IL200793A0 (en) | Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases | |
| MX2009009590A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| MX2009010037A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
| MX2009006690A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| EA200802118A1 (ru) | Обладающие ингибирующей активностью в отношении mnk1/mnk2 тиенопиримидины, предназначенные для применения в фармацевтических композициях | |
| PL2324008T3 (pl) | 3,4-diarylopirazole jako inhibitory kinazy białkowej | |
| TW200700093A (en) | Pharmaceutical composition for the treatment of cancer | |
| MX2009009592A (es) | Aminopiridinas utiles como inhibidores de proteinas cinasas. | |
| HK1124546A1 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| MX2009011811A (es) | Aminopirimidinas utiles como inhibidores de cinasa. | |
| MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
| EA200971107A1 (ru) | Катехоламиновые производные, полезные для лечения болезни паркинсона | |
| MX2007013624A (es) | Inhibidores de proteina cinasa. | |
| MX2007004248A (es) | Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa. | |
| TW200745088A (en) | Benzimidazoles useful as inhibitors of protein kinases | |
| EA200800011A1 (ru) | Тиенопиримидиновые и тиенопиридиновые модуляторы киназы | |
| MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
| WO2007064448A3 (en) | Cancer treatment using fts and 2-deoxyglucose | |
| MX2009011059A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
| HK1162502A1 (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3 |